Tongling Jieya Biologic Technology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: FMCG
  • ISIN: CNE1000054S9
CNY
21.80
0.16 (0.74%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Tongling Jieya Biologic Technology Co., Ltd.

Why is Tongling Jieya Biologic Technology Co., Ltd. ?

1
With a growth in Net Sales of 55.45%, the company declared Very Positive results in Mar 26
  • The company has declared positive results for the last 3 consecutive quarters
  • NET PROFIT(HY) At CNY 16.97 MM has Grown at 277.98%
  • OPERATING CASH FLOW(Y) Highest at CNY 160.46 MM
  • NET SALES(Q) At CNY 192.21 MM has Grown at 55.45%
2
With ROE of 3.83%, it has a very attractive valuation with a 0.74 Price to Book Value
  • Over the past year, while the stock has generated a return of -35.56%, its profits have risen by 979.5% ; the PEG ratio of the company is 0.1
  • At the current price, the company has a high dividend yield of 0.7
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Tongling Jieya Biologic Technology Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to FMCG should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in FMCG)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Tongling Jieya Biologic Technology Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Tongling Jieya Biologic Technology Co., Ltd.
-35.48%
-0.32
56.10%
China Shanghai Composite
17.95%
1.25
13.51%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0.67%
EBIT Growth (5y)
-22.83%
EBIT to Interest (avg)
30.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.74
Sales to Capital Employed (avg)
0.33
Tax Ratio
13.20%
Dividend Payout Ratio
36.42%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
23.50%
ROE (avg)
5.62%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
0.74
EV to EBIT
9.04
EV to EBITDA
5.72
EV to Capital Employed
0.57
EV to Sales
0.78
PEG Ratio
0.08
Dividend Yield
0.65%
ROCE (Latest)
6.29%
ROE (Latest)
3.83%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

24What is working for the Company
NET PROFIT(HY)

At CNY 16.97 MM has Grown at 277.98%

OPERATING CASH FLOW(Y)

Highest at CNY 160.46 MM

NET SALES(Q)

At CNY 192.21 MM has Grown at 55.45%

RAW MATERIAL COST(Y)

Fallen by -51.55% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 7.61 times

-18What is not working for the Company
INTEREST COVERAGE RATIO(Q)

Lowest at 819.41

DEBT-EQUITY RATIO (HY)

Highest at -37.85 %

INTEREST(Q)

Highest at CNY 1.44 MM

OPERATING PROFIT(Q)

Lowest at CNY 11.77 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 6.12 %

Here's what is working for Tongling Jieya Biologic Technology Co., Ltd.

Net Profit
At CNY 16.97 MM has Grown at 277.98%
Year on Year (YoY)
MOJO Watch
Net Profit trend is very positive

Net Profit (CNY MM)

Net Sales
At CNY 192.21 MM has Grown at 55.45%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (CNY MM)

Operating Cash Flow
Highest at CNY 160.46 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Inventory Turnover Ratio
Highest at 7.61 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost
Fallen by -51.55% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Tongling Jieya Biologic Technology Co., Ltd.

Interest
At CNY 1.44 MM has Grown at 131.1%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio
Lowest at 819.41
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Interest
Highest at CNY 1.44 MM
in the last five periods and Increased by 131.1% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Profit
Lowest at CNY 11.77 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 6.12 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Debt-Equity Ratio
Highest at -37.85 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio